Sunesis Pharmaceuticals (SNSS) is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of hematologic and solid tumor cancers. This stock is trading up 4% at $2.77 in recent trading.
Today's Range: $2.64-$2.8852-Week Range: $1.01-$3.17 Volume: 146,000 Three-Month Average Volume: 388,394 >>7 Pharma Buys for 2012 From a technical perspective, SNSS is bouncing modestly today right off a previous support zone at $2.63 with below average volume. This bounce today is forming a continuation pattern of higher lows for SNSS that has been in place for the last month and change. Traders should now look for long-biased trades in anticipation of a possible breakout above some near-term overhead resistance. That breakout will trigger once SNSS takes out $3.15 to $3.17 with high-volume. Look for volume on that move that's near or above 388,394 shares. If we get that action soon, look for SNSS to make a run at its next significant overhead resistance level at $3.69. I would avoid any long trades in SNSS if it breaks back below $2.63 with volume. Follow @stockpickr
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV